e-learning
resources
Vienna 2012
Sunday, 02.09.2012
COPD is not a pulmonary disease alone
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased sympathetic nerve activity in COPD is associated with elevated morbidity and mortality
H. Haarmann, S. Klarner, T. Raupach, S. Andreas (Goettingen, Immenhausen, Germany)
Source:
Annual Congress 2012 - COPD is not a pulmonary disease alone
Session:
COPD is not a pulmonary disease alone
Session type:
Poster Discussion
Number:
224
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Haarmann, S. Klarner, T. Raupach, S. Andreas (Goettingen, Immenhausen, Germany). Increased sympathetic nerve activity in COPD is associated with elevated morbidity and mortality. Eur Respir J 2012; 40: Suppl. 56, 224
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Evidence of impaired spontaneous baroreceptor sensitivity in patients with COPD as a potential link to cardiovascular morbidity and mortality
Source: Annual Congress 2012 - Modern clinical physiology: imaging structure and evaluating function
Year: 2012
Changes in physical activity and all-cause mortality in COPD
Source: Eur Respir J 2014; 44: 1199-1209
Year: 2014
COPD the unseen factor causing increased morbidity and mortality among IHD patients
Source: Annual Congress 2009 - COPD case-finding and management in primary care
Year: 2009
COPD is associated with an increased risk of peripheral artery disease and mortality
Source: ERJ Open Res, 4 (4) 00086-2018; 10.1183/23120541.00086-2018
Year: 2018
Increased work of breathing does not affect muscle sympathetic nerve activity in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 173s
Year: 2006
Early cardiovascular disease markers in "healthy" OSA patients are correlated with sympathetic activity
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011
Hyperinflation associated with COPD is associated with impaired cardiac function and spontaneous baroreceptor sensitivity
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Elevated pulmonary vascular resistance is associated with increased risk of death in IPF
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019
Increased relative mortality in women with severe oxygen-dependent COPD
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010
Elevated pulmonary vascular resistance predicts mortality in COPD patients
Source: Eur Respir J, 58 (2) 2100944; 10.1183/13993003.00944-2021
Year: 2021
Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD
Source: Eur Respir J 2016; 47:1365-1373
Year: 2016
Early rehabilitation is associated with reduced in-hospital mortality from sepsis in patients with sarcopenia
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019
Impact of intermittent hypoxia on cardiovascular morbidity and mortality
Source: Research Seminar 2005 - Adaptations to Hypoxia
Year: 2005
Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia
Source: Eur Respir J 2014; 43: 36-42
Year: 2004
Sustained maximal inspiratory pressure is significantly related to mortality risk in COPD
Source: International Congress 2017 – Best abstracts in the management of chronic respiratory diseases
Year: 2017
Colder temperature is associated with increased COPD morbidity
Source: Eur Respir J, 49 (6) 1601501; 10.1183/13993003.01501-2016
Year: 2017
Association of symptom subtypes and obstructive sleep apnoea-specific hypoxic burden with cardiovascular morbidity and all-cause mortality
Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders
Year: 2021
Increasing risk of exacerbation and mortality associated with increasing frequency and severity of exacerbations in COPD patients: EXACOS-UK
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Diaphragm dysfunction in combination with lung function decline is associated with higher mortality in idiopathic pulmonary fibrosis patients
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept